CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Planned sale Director sold 9,000 shares at $117.94 ($1,061,460)
- 144 Insider Sale of Securities
- 8-K Event Executive or director change · Shareholder vote results
- 4 Planned sale Director sold 9,000 shares at $107.68 ($969,120)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 9,000 shares at $99.64 ($896,760)
- 144 Insider Sale of Securities
- 4/A Planned sale President and CEO sold 75,000 shares at $100.12 ($7,509,000)
- 4 Open-market sale President and CEO sold 75,000 shares at $100.12 ($7,509,000)
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market sale Director sold 59,130 shares at an average $100.10 ($5,918,880)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 2 of 36 · 707 filings